The FDA’s clearance could double Kisqali’s breast cancer market. Elsewhere, Novo is exploring new ways to deliver genetic ...

The US FDA has added a boxed warning for hepatotoxicity and birth defects to the Filspari label. Image credit: sasirin pamai / Shutterstock. The US Food and Drug Administration (FDA) has converted the ...

The next time you unwrap a parcel, observe how many layers of packaging material you need to tear through to finally get your item. It is estimated that up to seven types 1 of packaging material go ...

The Packaging People, a leading packaging design company, reveals the art of brand storytelling through custom packaging design, a game-changing strategy that elevates brand identity and drives ...

Government regulations not only impose constraints but also drive innovation in packaging design. Credit: Mongta Studio via Shutterstock. Government regulations significantly influence packaging ...

NICE has recommended moving Novartis’ Kisqali (ribociclib) from interim funding arrangements to regular NHS reimbursement for certain previously treated breast cancer patients. In the final ...

Kisqali is a prescription drug used with other medications to treat certain kinds of breast cancer. Kisqali can cause side effects that range from mild to serious, such as fatigue, hair loss, and ...

Last December, we brought you a comprehensive rundown of the Packaging and Packaging Waste Regulation’s development throughout 2023. Now we’ve passed the halfway mark of 2024, and there are further ...

Online Supplies Ordering (OSO) is available to DHL Express account holders for the delivery of DHL packaging within Singapore. To make ordering supplies easier and to enhance security, the new version ...

The approval of Dupert is grounded in the outcomes of a Phase II clinical study. Credit: mi_viri/Shutterstock. China’s National Medical Products Administration (NMPA) has granted approval for Innovent ...

This type of tumor, referred in shorthand as HR+ and HER2-, accounts for roughly 70% of all breast cancer cases in the U.S. Kisqali specifically targets a protein called CDK4/6, as does Eli Lilly’s ...